Article Details

Enhertu Delays Progression of HER2-Low and Ultralow Metastatic Breast Cancer

Retrieved on: 2024-06-03 12:39:04

Tags for this article:

Click the tags to see associated articles and topics

Enhertu Delays Progression of HER2-Low and Ultralow Metastatic Breast Cancer. View article details on hiswai:

Excerpt

Antibody-drug conjugates use monoclonal antibodies to deliver a payload of chemotherapy drugs directly to. Enhertu, from Daiichi Sankyo and ...

Article found on: www.cancerhealth.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up